This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Dr. Remon Van Geel, PhD
Principal Scientist at Synaffix

Agenda Sessions

  • GlycoConnect® ADC Technology Readily Adapted for Site-Specific Conjugation of Cytokines and Oligonucleotides